Published: March 18, 2021
OxyContin maker Purdue Pharma filed a bankruptcy plan this week that would pay $500 million in cash to settle hundreds of thousands of injury claims linked to the company’s role in the nation’s opioid crisis. A group of state attorneys general immediately rejected the plan, NPR reports.